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Abstract: Uncombable hair syndrome (UHS), also known as "spun glass hair syndrome", "pili
trianguli et canaliculi", or "cheveux incoiffables" is a rare anomaly of the hair shaft
which occurs in children and improves with age. UHS is characterized by dry, frizzy,
spangly and often fair hair that is resistant to being combed flat. Up to date both
simplex and familial UHS cases with autosomal dominant as well as recessive
inheritance have been reported. However, none of these cases were linked to a
molecular genetic cause. Here, we report the identification of UHS causative mutations
located in the three genes PADI3 (peptidylarginine deiminase 3), TGM3
(transglutaminase 3) and TCHH (trichohyalin) in a total of eleven children. All of these
individuals carry homozygous or compound heterozygous mutations in one of these
three genes, indicating an autosomal recessive inheritance pattern in the majority of
UHS cases. The two enzymes PADI3 and TGM3, responsible for posttranslational
protein modifications, and their target structural protein TCHH, are all involved in hair
shaft formation. Elucidation of the molecular outcomes of the disease causing
mutations by cell culture experiments and tridimensional protein models demonstrated
clear differences in the structural organization and activity of mutant and wild type
proteins. Scanning electron microscopy observations revealed morphological
alterations in hair coat of Padi3 knockout mice. All together, these findings elucidate
the molecular genetic causes of UHS and shed light on its pathophysiology, and hair
physiology in general.
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Abstract 1 
Uncombable hair syndrome (UHS), also known as “spun glass hair syndrome”, “pili 2 
trianguli et canaliculi”, or “cheveux incoiffables” is a rare anomaly of the hair shaft 3 
which occurs in children and improves with age. UHS is characterized by dry, frizzy, 4 
spangly and often fair hair that is resistant to being combed flat. Up to date both 5 
sporadic simplex and familial UHS cases with autosomal dominant as well as 6 
recessive inheritance have been reported. However, none of these cases were linked 7 
to a molecular genetic cause. Here, we report the identification of UHS causative 8 
mutations located in the three genes PADI3 (peptidylarginine deiminase 3), TGM3 9 
(transglutaminase 3) and TCHH (trichohyalin) in a total of eleven children. All of these 10 
individuals carry homozygous or compound heterozygous mutations in one of these 11 
three genes, indicating an autosomal recessive inheritance pattern in the majority of 12 
UHS cases. The two enzymes PADI3 and TGM3, responsible for posttranslational 13 
protein modifications, and their target structural protein TCHH, are all involved in hair 14 
shaft formation. Elucidation of the molecular outcomes of the disease causing 15 
mutations by cell culture experiments and tridimensional protein models 16 
demonstrated clear differences in the structural organization and activity of mutant 17 
and wild type proteins. Scanning electron microscopy observations revealed 18 
morphological alterations in hair coat of Padi3 knockout mice. All together, these 19 
findings elucidate the molecular genetic causes of UHS and shed light on its 20 
pathophysiology, and hair physiology in general.  21 
 22 
  23 
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Introduction 24 
UHS [MIM 191480], was first described as a distinctive hair shaft defect in 1973.1; 2 25 
However, the phenotype had been recognized far earlier and had obtained notoriety 26 
as the famous literary character ‘Struwwelpeter-Shockheaded Peter’ from the 27 
children’s story published by the German physician Heinrich Hoffmann in 1845. This 28 
was later translated by Mark Twain to English as ‘Slovenly Peter’. Up to now about 29 
100 isolated and syndromic UHS cases have been reported.e.g. 3-5 Most of the cases 30 
are sporadic simplex occurrences but autosomal dominant or recessive inheritance 31 
patterns were also observed. In majority of the cases, UHS is an isolated condition of 32 
the hair, but it has occassionally been observed with additional symptoms, such as 33 
ectodermal dysplasias, retinopathia pigmentosa, juvenile cataract, and polydactyly. 34 
Isolated UHS is characterized by silvery, blond or straw colored scalp hair that is dry, 35 
frizzy and wiry, has a characteristic sheen, stands away from the scalp in multiple 36 
directions and is impossible to comb. This hair shaft disorder occurs in children and 37 
improves with age. The hair growth rate can range from slow to normal. The clinical 38 
diagnosis of UHS can be confirmed by scanning electron microscopy (SEM) analysis 39 
of hair shafts.6-8 In at least 50% of the hair examined, this reveals a triangular or 40 
heart-shaped cross-section, in comparison to the normal circular cross section, as 41 
well as longitudinal grooves along the entire length of the hair shaft.9 The hair is not 42 
more fragile or brittle than normal hair. No effective therapy is yet available although 43 
biotin supplementation was reported to be successful in some cases.10  44 
Up to date no genetic alteration had been linked to UHS although familial occurrence 45 
has been well observed. In this study, we report UHS causative mutations in PADI3 46 
[MIM 606755], TGM3 [MIM 600238] and TCHH [MIM 190370], encoding for hair shaft 47 
proteins that display sequential interactions with each other. Overexpression 48 
ofTransfection of cells with constructs encoding for wild type (WT) and mutant 49 
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proteins in cell culture shows showed that the identified PADI3 and TGM3 mutations 50 
have profound effects on enzymatic activity of the respective proteins. The 51 
observation of alterations in whiskers and hair coat of Padi3 knockout mice confirms 52 
the essential role of this enzyme in hair shaft morphology. Altogether, our findings 53 
implicate that UHS occurs when interactions of a structural protein that gives shape 54 
and mechanical strength to the hair shaft are impaired by defects either in this protein 55 
itself or in others that mediate its interactions.  56 
 57 
Materials and Methods 58 
Study participants 59 
Detailed information regarding the clinical descriptions of the individuals included in 60 
this study is given in the Supplemental Note: Case Reports. This study was 61 
performed according to the principles of the Declaration of Helsinki. Ethical approval 62 
was obtained from the ethics committee of the Medical Faculty of the University of 63 
Bonn and the participants provided written informed consent prior to blood sampling. 64 
Written informed consents of the affected individuals or their legal guardians were 65 
obtained for the publication of the case photos included in this manuscript. 66 
Scanning electron microscopy 67 
Hair shafts from various individuals with UHS and controls were mounted on stubs 68 
and sputter coated with either gold or platinum prior to examination in either a FEI 69 
Quanta FEG250 or a Philips 505 scanning electron microscope. 70 
Exome sequencing 71 
Exome sequencing was performed in two different centers. The two affected siblings 72 
of the discovery family from UK were exome sequenced by Oxford Gene 73 
Technology’s Genefficiency Sequencing Service. Genomic DNA (2 μg) was 74 
fragmented and enriched for human exonic sequences using the Human All Exon V5 75 
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Agilent Sure Select kit (Agilent Technologies) using the manufacturers protocol, and 76 
sequenced on the Illumina HiSeq 2000 platform using Truseq (v3 Chemistry) 77 
(Illumina) to generate 100 base paired-end reads. Fastq files were mapped to the 78 
reference human genome (hg19/GRCh37) using the Burrows-Wheeler Aligner (BWA) 79 
package (v0.6.2).11 Local realignment of the mapped reads around potential 80 
insertion/deletion (indel) sites was carried with the Genome Analysis Tool Kit (GATK) 81 
v1.6.12 Duplicate reads were marked using Picard v1.8 and BAM files were sorted 82 
and indexed with SAM tools v0.1.18.13 Approximately 12 and 14 GB of sequence 83 
data was generated for these samples and a minimum of 90.83% and 80.54% of the 84 
targeted exome was covered to a depth of at least 20× and 30× coverage, 85 
respectively. We filtered the variants for high-quality homozygous or potentially 86 
compound heterozygous, novel variants [defined against dbSNP 132 inclusion] that 87 
are shared by both siblings and are deleterious based on either of the SIFT, 88 
Polyphen and Condel predictions. 89 
The affected individuals from Germany and Turkey were exome sequenced at the 90 
Cologne Center for Genomics. For whole-exome sequencing, 1 μg of genomic DNA 91 
was fragmented with sonication technology (Bioruptor, Diagenode). The fragments 92 
were end-repaired and adaptor-ligated, including incorporation of sample index 93 
barcodes. After size selection, a pool of all 5 libraries was subjected to an enrichment 94 
process with the SeqCap EZ Human Exome Library version 2.0 kit (Roche 95 
NimbleGen). The final libraries were sequenced on an Illumina HiSeq 2000 96 
sequencing instrument (Illumina) with a paired-end 2× 100 bp protocol. Primary data 97 
were filtered according to signal purity by the Illumina Realtime Analysis (RTA) 98 
software v1.8. Subsequently, the reads were mapped to the human genome 99 
reference build hg19 using the BWA-aln alignment algorithm.11 GATK v.1.6 was used 100 
to mark duplicated reads, to do a local realignment around short insertions and 101 
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deletions, to recalibrate the base quality scores and to call SNPs and short Indels.12 102 
For the Turkish individual this resulted in 7.5 Gb of unique mapped sequences, a 103 
mean coverage of 94 and 30× coverage of 91% of the target sequences. For the 104 
German individual, this resulted in 8.1 Gb of unique mapped sequences, a mean 105 
coverage of 106 and 30× coverage of 92% of the target sequences. The Varbank 106 
pipeline v.2.10 and interface developed in-house at the Cologne Center for Genomics 107 
were used for data analysis and filtering (unpublished data, H.T., J.A., and P.N.). The 108 
GATK UnifiedGenotyper variation calls were filtered for high-quality (DP>15; AF>0.25 109 
+ VQSLOD >-8 if possible, otherwise: QD>2; MQ>40; FS<60; MQRankSum>-12.5; 110 
ReadPosRankSum>-8; HaplotypeScore <13) rare (MAF ≤ 0.005 based on 1000 111 
genomes build 20110521 and EVS build ESP6500) variants, predicted to modify a 112 
protein sequence or to impair splicing, in homozygous or compound heterozygous 113 
state. 114 
Sanger Sequencing  115 
Amplicons were generated under standard polymerase chain reaction conditions by 116 
using primers presented in Tables S1-S3. Sanger sequencing was performed using 117 
the BigDye Terminator v1.1 Cycle Sequencing kit (Applied Biosystems) and an ABI 118 
3100 genetic analyzer (Applied Biosystems). The data were analyzed using SeqMan 119 
II software (DNASTAR). 120 
Molecular cloning and mammalian cell cultures 121 
To construct the expression vectors for PADI3 and TGM3, the coding sequences 122 
(cDNA) of PADI3 (1995 bp) and TGM3 (2082 bp), were amplified from hair follicle 123 
cDNA, and cloned into the TOPO cloning site of pcDNA 3.1/V5-His-TOPO vector 124 
(Invitrogen) according to manufacturer’s protocol. The mutant constructs (PADI3: 125 
c.335T>A [p.Leu112His], c.881C>T [p.Ala294Val], c.1813C>A [p.Pro605Thr] and 126 
TGM3: c.1351C>T [p.Q451Gln451*]) were generated by targeted mutagenesis using 127 
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QuickChange II Site-Directed Mutagenesis kit (Agilent Technologies) according to 128 
manufacturer’s instructions. The constructs were verified by Sanger sequencing. The 129 
primers used for cloning and mutagenesis are listed in Table S4. The HaCaT human 130 
keratinocyte cell line was established by Boukamp et al. (1988). 14 The HEK293T cell 131 
line was a kind gift from Thomas Zillinger (Institute of Clinical Chemistry and Clinical 132 
Pharmacology, University of Bonn). Both HaCaT and HEK293T cell lines were tested 133 
for mycoplasma contamination and confirmed to be mycoplasma free. Cells were 134 
maintained at 37oC (5% CO2) in DMEM (Lonza) supplemented with 10% FCS (Life 135 
Technologies), 1%  Penicilin- streptomycin (10,000 U ml-1, Life Technologies) and 1%  136 
Amphotericin B (250 µg ml-1, Life Technologies). Cells were cultured in 10 cm Petri 137 
dishes and on coverslips in 24-well plates for western blotting and 138 
immunofluorescence analysis, respectively. Transfections were carried on using the 139 
Lipofectamine3000 Transfection Kit (Life Technologies) according to manufacturer’s 140 
instructions. For each 10 cm plate, the following amounts of reagents were used: 15 141 
µg plasmid, 1500 µl Opti-MEM (Life Technologies), 22.5 µl Lipofectamine3000 and 142 
30 µl P3000 reagent. For each well in a 24-well plate, 0.5 µg of plasmid, 50 µl Opti-143 
MEM, 1.5 µl Lipofectamine3000 and 1 µl P3000 reagent were used. Cells were 144 
harvested 48 h post-transfection.  145 
Topological tridimensional models of PADI3 146 
We constructed, as we had previously published,15 a topological tridimensional model 147 
of WT PADI3 using the crystal atomic coordinates of calcium-bound human PADI4 148 
(Protein Data Bank accession number 1WDA).16 On this basis, topological models of 149 
the tridimensional structure of the three mutated enzymes were produced after in 150 
silico substitutions of the respective amino acids. All the models were refined by 151 
energy minimization (3x3000 iterations) using the MSI insight II modules Biopolymer, 152 
CHARMM and Viewer on an O2 SGI station. Energetic potentials after minimization 153 
9 
 
were all improved and validated. The three models were then validated by analyses 154 
of “Anolea data” and Ramachandran plots produced using the Swiss model expasy 155 
structure assessment tools and the Swiss-Pdb viewer software version 4.04, 156 
respectively. Finally, topological models of mutated PADI3 were individually 157 
compared to that of WT PADI3 after a magic fit on Swiss-Pdb viewer. Solid ribbon 158 
representations were displayed to show overviews of the tridimensional structures or 159 
enlargements focused on either the catalytic sites or the five calcium binding sites. 160 
Immunoblotting of HaCaT and HEK293T cell extracts  161 
Cells were collected in ice-cold PBS and centrifuged at 150 x g at 4°C for 10 min. 162 
The cell pellets were re-suspended in 40 µl of 10x RIPA buffer (Cell Signaling 163 
Technology) and 360 µl Protease Inhibitor Cocktail (Roche), incubated on ice for 15 164 
min and sonicated 10 times for 10 sec, with 10 sec breaks on ice. After centrifugation 165 
at 10,500 x g for 10 min at 4°C, the supernatants were transferred to clean tubes and 166 
purified with Micro Bio-Spin Columns (Bio-Rad Laboratories) according to 167 
manufacturer’s instructions. Purified lysates were mixed with 4x Laemmli sample 168 
buffer (Bio-Rad Laboratories) diluted in β-mercaptoethanol. After protein separation 169 
on TGX stain-free gels 4-15% (Bio-Rad Laboratories), the proteins were transferred 170 
on PVDF membrane (Amersham Biosciences). Western blotting was carried out 171 
using the WesternBreeze chemiluminescent kit (Invitrogen) according to 172 
manufacturer’s instructions. The following primary antibodies were used with an 173 
incubation duration of 1h: mouse monoclonal anti-V5 (1:5000, V8012, Sigma Aldrich) 174 
and rabbit monoclonal anti-PADI3 / PAD3 (1:400, ab172959, Abcam) for PADI3 175 
detection, mouse monoclonal anti-Flag (1:5000, F1804, Sigma Aldrich) and rabbit 176 
polyclonal anti TGM3-C-terminal (1:250, OAAB12971, Aviva Systems Biology) for 177 
TGM3 detection. Membranes were developed using the ChemiDoc MP imager (Bio 178 
Rad) for a maximum of 20 min. Data in Figure 4A are representative of western 179 
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blotting experiments from three independent transfections of HaCaT cells with PADI3 180 
constructs. Data in Figure 7A and Figure S7 emerge from six independent 181 
transfections of HaCaT (1x) and HEK293T (5x) cells with TGM3 constructs. The 182 
relative quantities of WT and mutated TGM3 were assessed using Stain-Free 183 
technology that is based on total protein normalization (Bio-Rad Laboratories).17  184 
Immunofluorescence analysis in HaCaT and HEK293T cells  185 
Transiently transfected HaCaT and HEK293T cells grown on coverslips were washed 186 
with 1x PBS for 5 min, permeabilized for 10 min with 1% Triton X-100 and blocked for 187 
1h in PBS containing 1% bovine serum albumin, 10% normal goat serum and 0.1% 188 
Triton X-100. The cells were incubated with mouse monoclonal anti-V5 primary 189 
antibody (1:100, V8012, Sigma Aldrich) or mouse monoclonal anti-Flag antibody 190 
(1:500, F1804, Sigma Aldrich) for PADI3 and TGM3, respectively, for 3h at RT (or 191 
overnight at 4oC) and goat anti-mouse-cy3 secondary antibody (1:500, A10521, Life 192 
Technologies) with DAPI (D9542, Sigma Aldrich) for 40 min. The mounting was 193 
performed with Mowiol 4-88 (Roth). Images were captured with 63x or 10x oil 194 
immersion objectives using a Zeiss Axioplan 2 imaging microscope and the 195 
Cytovision 7.4 software. ImageJ was used for the analyses by applying the same 196 
brightness and contrast thresholds to all data. Data presented in Figure 4B and 197 
Figure 7B are representative of analyses from four independent transfections of 198 
HaCaT cells with PADI3 constructs and five independent transfections of HaCaT (3x) 199 
and HEK293T (2x) cells with TGM3 constructs, respectively. Two to three coverslips 200 
were analyzed per construct at each transfection.  201 
Activity of PADI3 in HaCaT cells 202 
Transiently transfected HaCaT cells grown on coverslips were air-dried. For indirect 203 
immunofluorescence, the cells were rehydrated for 15 min in PBS and permeabilized 204 
for 10 min in PBS containing 1% Triton X-100, and then non-specific binding sites 205 
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were blocked with PBS containing 2% fetal bovine serum and 1% Triton X-100. 206 
Slides were incubated with the following primary antibodies: mouse monoclonal anti-207 
V5 (1:100, R960-25, Thermo Fisher Scientific) and ACPA antibodies (6 µg ml-1) 208 
purified from a pool of rheumatoid arthritis [MIM 180300] patient sera.18; 19 Sera were 209 
from informed and consenting individuals attending the Rheumatology Center of 210 
Toulouse and have been declared to and approved by the Comité de Protection des 211 
Personnes Sud Ouest et Outre-Mer II (Toulouse, France). After incubation with the 212 
corresponding secondary antibodies, Alexa Fluor 488 Donkey anti-mouse IgG 213 
(1:10000, A21202, Thermo Fisher Scientific), Alexa Fluor 555 Goat Anti-human IgG 214 
(H+L) (1:10000, A21433, Thermo Fisher Scientific), and DAPI (D9542, Sigma-215 
Aldrich), slides were mounted in Mowiol 4-88 (Calbiochem Merck Millipore). Images 216 
were captured with 20x dry or 63x oil immersion objectives using a Zeiss apotome 217 
microscope (Carl Zeiss). ImageJ was used for the analyses by applying the same 218 
brightness and contrast thresholds to all data. Data presented in Figure 5A are 219 
representative of analyses from two independent transfections of HaCaT cells with 220 
three coverslips for each single PADI3 construct.  221 
Activity of PADI3 produced in Escherichia coli  222 
E coli strain BL21(DE3)-pLysS (Life Technologies) were transformed with 5 ng of the 223 
recombinant expression plasmids (pcDNA3.1/V5-His-TOPO–PADI3-WT, 224 
pcDNA3.1/V5-His-TOPO–PADI3-p.Leu112His, pcDNA3.1/V5-His-TOPO–PADI3-225 
Arg294Thr p.Arg294Val and pcDNA3.1/V5-His-TOPO–PADI3-p.Pro605Thr) and 226 
grown at 37°C overnight on agar-Luria Broth plates (MP Biomedicals) supplemented 227 
with ampicillin (50 µg ml-1) and chloramphenicol (34 µg ml-1). Four clones were 228 
selected for each plasmid. After selection, the bacterial clones were grown in Luria 229 
Broth medium supplemented with ampicillin (50 µg ml-1), at 37°C for 3 hours and then 230 
overnight at 30°C. Harvested bacteria were sonicated 4x8 seconds (6~10W) on ice in 231 
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a Tris-HCl pH 7.6 buffer containing a cocktail of bacterial protease inhibitors (Sigma 232 
Aldrich). After centrifugation at 9,000 x g for 10 min, soluble proteins were recovered 233 
in the supernatants (clarified extracts).  234 
To measure an in vitro deimination activity, the clarified extracts were incubated at 235 
37°C in 100 mM Tris-HCl pH 7.6 buffer containing 10 mM CaCl2 and 5 mM DTT, for 236 
either 2 hours or overnight, under agitation at 1400 rpm.20 The deimination reactions 237 
were stopped by boiling for 3 min in Laemmli’s sample buffer. The proteins were then 238 
separated by SDS-polyacrylamide (10%) gel electrophoresis and immunodetected 239 
with the V5 Epitope Tag monoclonal antibody (1:5000, R960-25, Thermo Fisher 240 
Scientific) and the anti-modified citrulline antibodies.21; 22 The blots were developed 241 
using the ECL primeTM system (GE Healthcare) as described by the manufacturer. 242 
Immunoblotting signals were recorded using a G:BoxTM Chemi XT4 imager and 243 
GeneTool analysis software (Syngene) for a maximum of 20 min.  244 
After one bacteria transformation, two independent clones for p.Leu112His, three for 245 
p.Pro605Thr and four for WT and p.Ala294Val were analyzed, with identical results; 246 
only those corresponding to two clones are illustrated. Data are representative of two 247 
technical replicates. The V5-antibody detections of recombinant PADI3 were 248 
confirmed using an anti-PADI3 antibody.22 249 
Padi3-deficient mice 250 
All experiments with animals were approved by a local ethic committee (INSERM 251 
US006 CEEA-122) and carried out according to our Institution guidelines and EU 252 
legislation. Padi3-deficient mice (B6NCrl;B6N-Atm1BrdPadi3tm1a(KOMP)Wtsi/Or, 253 
abbreviated to Padi3tm1a) were generated by the Phenomin Program at the ICS 254 
Laboratory (Strasbourg, France). A promoter-less LacZ-reporter cassette containing 255 
a neomycin-resistance gene and flanked by two flippase recognition target sites was 256 
inserted between exons 4 and 5 of the Padi3 gene, with loxP sites flanking the exons 257 
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5 and 6. See http://www.mousephenotype.org/data/search/gene?kw=padi3 for more 258 
details. Mice were maintained in the TAAM animal facility (CNRS UPS44, Orléans, 259 
France) under pathogen-free conditions. They were killed by cervical dislocation. All 260 
efforts were made to minimize suffering. The following oligonucleotides were used for 261 
genotyping: Padi3 forward (5′-CTTTATTGATAAACACAGGCAGGGAGC-3′), Padi3 262 
reverse (5′-CAATGGAATCCCTCTGTCCCTCACC-3′), and LacZ reverse (5’-263 
CCAACAGCTTCCCCACAACGG-3’). A wild type PCR product of 241 bp and a tm1a 264 
allele product of 365 bp were produced. Genotyping was confirmed using the Padi3 265 
forward (5‘-CCCTCTTTGAGGACCACAGGCTTATC-3’) and reverse (5’-266 
GCACTCAAGAAGCAGAGGCAGGC-3’) primers, a wild type PCR product of 369 bp 267 
and a tm1a allele product of 421 bp were produced. No randomization was used. The 268 
SEM observations of whiskers and hair coat were done in blind, by two independent 269 
scientists. 270 
Transglutaminase activity of TGM3  271 
In order to compare the enzymatic activity of WT and mutant TGM3 in cell extracts of 272 
transiently transfected HEK293T cells we adapted the transglutaminase assay 273 
described by Aufenvenne et al. (2009).23 This assay is based on the incorporation of 274 
monodansylcadaverine into casein by transglutaminase, which causes an 275 
augmentation of fluorescence and an emission wavelength shift. Lysates of cells 276 
transiently transfected with WT or mutant TGM3 constructs were prepared 48 h post-277 
transfection as described in the immunoblotting section. Lysates of mock-transfected 278 
cells were used as a negative control. The overexpression translation of the target 279 
proteins was always confirmed by immunoblotting. For the assay, the lysates were 280 
incubated for 15 min in pre-warmed assay buffer (50 mM Tris/HCl, 10 mM CaCl2, 10 281 
mM reduced glutathione, 2.5% glycerol, 2.5% DMSO, 25 µM monodansylcadaverine, 282 
20 mM N,N-dimethylcasein, pH 8) at 37°C. Measurements were then made for 10 283 
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min at 37°C using a LS55 fluorescence spectrometer (Perkin Elmer) with excitation 284 
and emission wavelengths of 332 nm and 500 nm, respectively, and a 5.0 nm slit. 285 
The linear slopes of the measurements from technical triplicates of samples 286 
emerging from five independent transfections were used as a measure of the 287 
transglutaminase activity.23 The activity data were not normally distributed (P < 0,050, 288 
Shapiro-Wilk) and analyzed by a Kruskal-Wallis test (One Way ANOVE on Ranks) 289 
with post hoc Dunn's pairwise multiple comparisons test. 290 
 291 
Results 292 
Identification of mutations in PADI3, TGM3 and TCHH 293 
In this study, we identified UHS causative mutations in three functionally related 294 
genes in a total of 11 individuals/families (Figure 1, Table 1 and Supplemental Note: 295 
Case Reports). The first family originated from the U.K. and had two affected and two 296 
unaffected siblings. The affected individuals reported typical hair problems in 297 
childhood with improvement while growing older (Figure 1J); gross and scanning 298 
electron microscopy observations were in line with an UHS phenotype (Figure 1K-L). 299 
In order to elucidate the genetic background of UHS in this family, we performed 300 
whole exome sequencing (WES) in both of the affected siblings. We filtered the data 301 
for novel and deleterious homozygous or potentially compound heterozygous 302 
variants that are shared by the siblings and identified a homozygous missense 303 
variant c.881C>T (p.Ala294Val) within PADI3 (GenBank: NM_016233.2). The 304 
mutation co-segregated with the disease phenotype in the family (Figure 2A, Figure 305 
S1).  306 
Then, we Sanger sequenced PADI3 in seventeen additional sporadic cases and 307 
detected the above mentioned mutation as well as two other recurrent missense 308 
mutations, c.335T>A (p.Leu112His) and c.1813C>A (p.Pro605Thr), in seven other 309 
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individuals/families24; 25 (Table 1, Figure 2B-C, and Figure S2). We also identified an 310 
individual who carries the discovery mutation c.881C>T (p.Ala294Val) and a 311 
nonsense mutation, c.1732A>T (p.Lys578*), that occurred only once in our UHS 312 
cohort (Table 1, Figure 2B-C and Figure S2). These mutations were observed either 313 
in homozygous state or in compound heterozygosity as confirmed by parental DNA 314 
sequencing in three of the families (Figure S1). The allele frequencies of the PADI3 315 
substitutions from Exome Aggregation Consortium (ExAC) data are presented in 316 
Table S5. The nonsense mutation was not observed in ExAC.  317 
As a next step, we performed WES in four further UHS cases with no PADI3 318 
mutations. We identified the nonsense mutation c.1351C>T (p.Gln451*) in TGM3 319 
(GenBank: NM_003245.3) in a Turkish individual26 and the nonsense mutation 320 
c.991C>T (p.Gln331*) in TCHH (GenBank: NM_007113.3) in a German individual 321 
(Figure 2D-G;  Table S5). No homozygous loss of function mutations were observed 322 
in TGM3 or TCHH in ~60,000 sequenced individuals of the ExAC database. 323 
PADI3, TGM3 and TCHH interplay in hair shaft formation 324 
PADI3, a gene of the PADI family (PADI1-4 and 6), encodes the 664-amino acid 325 
peptidylarginine deiminase type III (Enzyme Commission number, EC.3.5.3.15).27 326 
This posttranslational modification enzyme converts positively charged L-arginine 327 
residues of proteins into neutral citrulline residues in the presence of calcium ions. 328 
The process is called deimination or citrullination. PADI3 is mainlyexpressed  329 
detected in skin, including hair follicles where it modifies hair shaft proteins.28; 29 330 
Although the enzyme has already been a focus of interest in hair biology, it could not 331 
be linked to any disorder until now. TGM3 encodes transglutaminase 3, a member of 332 
the transglutaminase family (EC.2.3.2.13), which catalyzes the calcium-dependent 333 
formation of isopeptide bonds between glutamine and lysine residues in various 334 
proteins including the archetypal hair shaft protein trichohyalin, encoded by TCHH. 335 
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TCHH is a structural protein located and co-expressed localized with PADI3 in the 336 
inner root sheath of the hair follicle and in the medulla of the hair shaft. Deimination 337 
by PADI3 reduces the overall charge of TCHH, and that enables its association with 338 
the keratin intermediate filaments (KIF). Then, TCHH and KIF are crosslinked 339 
together by TGM3. KIFs are then stabilized, hardened and linked to cornified 340 
envelopes through further crosslinking by transglutaminases, particularly by TGM3 341 
(Figure 2H).30-32 Thereby, TCHH and its sequential modifications by PADI3 and 342 
TGM3 have a very important role in shaping and mechanical strengthening of the 343 
hair. Of note, the TCHH mutation we identified leads to the synthesis, if any, of a very 344 
short protein, probably without any function in KIF interaction as the KIF interacting 345 
domain would be almost entirely missing (Figure 2G).  346 
Missense mutations in PADI3 affect the 3-D enzyme structure  347 
We next investigated the consequences of PADI3 mutations on the corresponding 348 
proteins. The p.Lys578* is expected to induce the synthesis of a truncated protein 349 
lacking the 87 amino acids of the carboxy terminal, in particular the Cys646 (Figure 350 
2C,  Table S6) absolutely necessary for the enzyme activity.28 Intriguingly, we 351 
observed that the three PADI3 amino acids substituted as a result of the missense 352 
mutations correspond to residues that are conserved in the five human PADI 353 
proteins, and also in the PADI3 from other species, suggesting they have an 354 
important role (Figure S3). However, none of them is directly involved in the catalytic 355 
site or in one of the five calcium-binding sites of PADI3 (Table S6). Nevertheless, 356 
when we analyzed the effect of the PADI3 missense mutations on the predicted 357 
three-dimensional structure of the enzyme,15 the mutations p.Ala294Val and 358 
p.Pro605Thr were shown to induce clear modifications of beta-sheets and alpha-359 
helices, in particular in the immunoglobulin-like NH2 domains, and also around the 360 
catalytic site and the calcium-binding sites. The effects of the p.Leu112His 361 
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substitution were less drastic (Figure 3 and Figures S4, S5).  362 
Aggregation and reduced enzymatic activity of PADI3 mutants  363 
We then cloned the wild-type WT PADI3 cDNA into a mammalian expression vector 364 
in order to express induce the translation of a C-terminally V5-tagged PADI3 protein. 365 
Mutant constructs with the three recurrent missense mutations were generated by 366 
targeted mutagenesis. HaCaT cells were transiently transfected (5-10% transfection 367 
efficiency) with constructs encoding for WT and mutant forms of PADI3 were 368 
overexpressed in the transiently transfected HaCaT human keratinocyte cell line (5-369 
10% transfection efficiency). Immunoblotting of cell extracts showed that all of the 370 
constructs led to the WT and mutated PADI3 constructs led to expression translation 371 
of a protein of about 70 kDa (Figure 4A). The subcellular location of WT and mutated 372 
proteins was determined by immunofluorescence analyses that showed, as 373 
expected, a diffuse homogenous cytoplasmic distribution of the WT PADI3,22 374 
whereas in all three mutants the proteins were observed to form large aggregates 375 
throughout the cytoplasm (Figure 4B). To assess the enzymatic activity of WT and 376 
mutated PADI3, we performed double immunostaining with an anti-V5 monoclonal 377 
antibody and with human anti-citrullinated protein autoantibodies (ACPA) from 378 
individuals with rheumatoid arthritis patients, these antibodies specifically detecting 379 
citrullinated proteins.18; 33 While overexpression translation of the WT PADI3 resulted 380 
in a strong labeling with the ACPA antibodies, the signal in the cells expressing 381 
producing the mutant proteins was barely above background (Figure 5A). We also 382 
produced the WT and mutant PADI3 in E. coli. After incubation of the WT PADI3-383 
containing bacterial extracts with calcium for two hours, deiminated proteins were 384 
detected. By contrast, when the extracts containing the mutated PADI3 were 385 
incubated for two hours, and even up to eighteen hours, no deiminated proteins were 386 
detected (Figure 5B and Figure S6). Altogether, the results suggested that the 387 
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mutated forms of PADI3 are either not or only weakly active.  388 
Padi3 knockout mice show whisker and hair anomalies 389 
In order to demonstrate the importance of PADI3 in hair shaft formation and 390 
structure, we generated Padi3 knockout mice (Figure 6A-B). Breeding mice 391 
heterozygous for the Padi3tm1a mutation produced offspring with the three possible 392 
genotypes at the expected Mendelian ratios, showing that absence of Padi3 is 393 
compatible with life. Grossly, the skin of 7-weeks old null mice appeared normal. A 394 
further characterization by SEM revealed alterations in the morphology of hair coat 395 
(Figure 6C) and, less markedly, of whiskers. The surface of the lower (proximal) part 396 
of the vibrissae and the hairs on their entire length were irregular and rough and 397 
appeared as hammered. 398 
Nonsense mutation in TGM3 leads to reduced enzymatic activity 399 
We cloned the WT TGM3 cDNA into a mammalian expression vector in order to 400 
express induce the translation of an N-terminally FLAG-tagged TGM3 protein. Mutant 401 
construct was generated by targeted mutagenesis. WT and mutant TGM3 were 402 
overexpressed in the transiently transfected HaCaT and HEK293T cell lines were 403 
transiently transfected with WT and mutant TGM3 encoding constructs. WT TGM3 404 
construct produced led to translation of a protein of about 70 kDa, while the mutated 405 
constructnonsense mutation resulted in a truncated protein of around 40 kDa with a 406 
lower detection level (Figure 7A and Figure S7). Immunofluorescence analysis 407 
showed that TGM3 is located in the cytoplasm and that the truncated form is present 408 
in a dramatically lower number of cells (Figure 7B) in accordance with the western 409 
blot results. Generally these cells had a smaller cytosolic surface area in comparison 410 
to those overexpressing producing the WT TGM3 (Figure 7B). We performed a 411 
transglutaminase activity assay23 with HEK293T cell lysates overexpressing 412 
containing WT and mutated TGM3. The analysis results revealed that the WT had a 413 
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significantly higher transglutaminase activity in comparison to the truncated protein 414 
and the latter did not differ from the mock transfected negative control (Figure 7C and 415 
Figure S8).  416 
 417 
Discussion 418 
In this study we identified disease causative mutations for UHS in PADI3, TGM3 and 419 
TCHH with the former two genes encoding for posttranslational modification enzymes 420 
that act on the structural hair protein trichohyalin encoded by the latter gene. Our cell 421 
culture data show that the identified mutations in PADI3 and TGM3 lead to reduced 422 
or no enzymatic activity and the phenotype of the Padi3 knockout mice we generated 423 
show structural alterations in the whiskers and hair coat morphology. Our findings are 424 
also supported by the phenotype of the already existing Tgm3 knockout mice. These 425 
mice exhibit irregular, twisted whiskers and, at birth, have a wavy hair coat, which 426 
improves four weeks after birth.34 Scanning and transmission electron microscopy 427 
analyses of hairs from adult Tgm3-/- mice reveal alterations such as irregular torsions, 428 
deformed grooves, abnormal cuticle and shorter KIF.34 It is also convincing that, both 429 
nonsense and missense mutations in the Tgm3 gene are responsible for the 430 
wellhaarig mouse phenotype, named for the curly whiskers and wavy coat of the 431 
mutant animals.35 Based on the phenotype of the Tgm3-/- mice, John et al. have 432 
suggested that alterations in TGM3 or its substrates could be related to recessive 433 
forms of pili torti [MIM 261900] or similar hair phenotypes, which improve with age.34 434 
Our findings validate this hypothesis and furthermore identify UHS as the hair 435 
phenotype related to alterations not only in TGM3 but also in the other proteins of the 436 
TCHH-PADI3-TGM3 interplaycascade. In some affected individuals, TCHH would not 437 
be produced, or produced as a truncated form unable to interact with KIF; in others, 438 
because of a PADI3 activity defect, TCHH would remain insoluble preventing its 439 
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interaction with KIF; in the last group, TCHH/KIF interaction would not be stabilized 440 
by TGM3-mediated crosslinks. Taken together, this suggests that one of the 441 
particular processes in hair shaft formation that leads to UHS when disturbed might 442 
be the interaction of TCHH and KIF. This interaction is known to be crucial for 443 
shaping and mechanical strengthening of the hair shaft. These findings also show 444 
that the compromise of any one of the proteins that play a role in this process would 445 
be enough to lead to the same phenotype.  446 
It is intriguing that, despite the defects affecting a structural component of the hair 447 
shaft, the phenotype in UHS is commonly reported to improve with age, similar to the 448 
hair coat phenotype of Tgm3-/- mice. Interestingly, improvement with age has also 449 
been observed in other hair shaft disorders (e.g. pili annulati, pili torti). The 450 
improvement in UHS might be due to the compensatory expression of another 451 
isoform of peptidylarginine deiminase, transglutaminase or other structural hair shaft 452 
components. On the other hand, aging related changes in hair follicles such as 453 
increase in diameter and length can have mechanistic influences that might account 454 
for this improvement.  455 
TGM3 and PADI3 are strongly detected in the upper epidermis. Nevertheless, no 456 
anomalies have been reported in the interfollicular epidermis of individuals with 457 
isolated UHS. Similarly, Tgm3-/- mice show no obvious skin defects.34 This is 458 
probably due to the fact that other isoforms of these enzyme families are present in 459 
the epidermis, which can compensate for the loss of PADI3 and TGM3 activity, 460 
whereas these two are the only isoforms detected in the hair cuticles and medulla.27; 461 
28; 30 462 
Up to now, both sporadic simplex and familial cases of UHS have been reported with 463 
suggested autosomal dominant and recessive inheritance with variable levels of 464 
penetrance. In this study we consistently observed an autosomal recessive 465 
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inheritance pattern in a total of 11 familial and sporadic simplex cases. Based on the 466 
pedigrees reported in literature, it is most likely that autosomal dominant forms of this 467 
condition exist7; 36; 37 which might be underlined by defects in other genes involved in 468 
hair shaft formation and maintenance related processes. It would be of interest then 469 
to investigate closely whether differences could be observed in the phenotypes of 470 
these individuals in comparison to the individuals who carry recessive mutations in 471 
PADI3-TCHH-TGM3 interplaycascade.   472 
An interesting observation was that, 5 out of 60,659 individuals in ExAC are 473 
homozygous for c.881C>T (p.Ala294Val). UHS is a non-debilitating phenotype that 474 
resolves with age and therefore, it is likely that these presumably affected individuals 475 
had participated in the ExAC project as "healthy" controls. This data also indicates 476 
that UHS is a more common phenotype than estimated.  477 
In summary, we elucidated the molecular genetic background of UHS by identifying 478 
recessive mutations in PADI3, TCHH and TGM3. The three genes encode for 479 
proteins that play an essential role during hair shaft formation through their sequential 480 
interactions. This finding, in combination with the data describing the functional 481 
effects of the mutations in PADI3 and TGM3, provides valuable information regarding 482 
the pathophysiology of UHS. Furthermore, it contributes to a better understanding of 483 
the protein interaction cascades in molecular histogenesis of the hair. This could be 484 
of further value for cosmetics and pharmaceutics industries paving the way for 485 
development of novel products. 486 
 487 
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Figure Legends  651 
Figure 1. Clinical appearance of UHS 652 
(A-G) Clinical presentation of UHS. Typical signs of UHS can be observed in (A-C) 653 
three German girls, (D) a German boy, (E) a Swiss boy, and (F-G) a Danish girl, who 654 
were included in the study. (G) The improvement of the phenotype with aging can be 655 
observed in the Danish girl. (H) SEM image of the Danish girl’s hair shaft showing the 656 
longitudinal groove (I) in comparison to a normal hair shaft. (J) The improved hair 657 
phenotype at age 15 and (K-L) the SEM findings of the male sibling from the UK 658 
family. (K) Longitudinal grooves and (I) heart-shaped cross section of hair presented 659 
(M) in comparison to the circular cross section from a control hair shaft, are indicative 660 
of UHS. Detailed information regarding the clinical histories can be found in the 661 
Supplemental Note; Case Reports.  662 
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Figure 2. Mutations causing UHS and interplay of PADI3, TGM3 and TCHH  663 
(A) The homozygous c.881C>T (p.Ala294Val) mutation in PADI3 identified by exome 664 
sequencing in the UK siblings was verified by Sanger sequencing. The mutation co-665 
segregates with the UHS phenotype in the pedigree as shown in Figure S1. (B) 666 
Electropherograms show the PADI3 mutations c.335T>A (p.Leu112His), c.1813C>A 667 
(p.Pro605Thr) and c.1732A>T (p.Lys578*) in comparison to the wild type sequences. 668 
(C) Schematic representation of PADI3 showing the various domains of the protein, 669 
the positions of calcium-binding sites (*), and of major amino acids involved in the 670 
catalytic sites (v). The positions of the mutations substitutions responsible for UHS 671 
are indicated by an arrow. (D) Electropherograms show the homozygous TGM3 672 
mutation c.1351C>T (p.Gln451*) identified in the Turkish male in comparison to the 673 
wild type sequence. (E) Schematic representation of TGM3. (F) Electropherograms 674 
show the homozygous TCHH mutation c.991C>T (p.Gln331*) identified in the 675 
German female in comparison to the wild type sequence. (G) Schematic 676 
representation of TCHH. (H) Cartoon depicting the interplay cascade of interactions 677 
between TCHH, PADI3 and TGM3 in hair shaft biology. In trichohyalin granules (grey 678 
areas), TCHH appears as a dimer with a long rod-shaped domain and a globular end 679 
domain. After deimination by PADI3, TCHH is less structured, and the granules 680 
progressively dissolved. Citrullinated-TCHH (TCHH-Cit) interacts with keratin 681 
intermediate filaments (black lines) organizing them, and becomes a substrate for 682 
TGM3. Cross-links of TCHH to itself (intra- or inter-chains), to keratins and between 683 
keratins and the cornified cell envelope components are then catalyzed (green dash). 684 
685 
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Figure 3. Topological tridimensional models of WT and mutant PADI3 686 
(A) Overall view of the tridimensional solid-ribbon representation of calcium-bound 687 
WT and three mutant PADI3 models. The tridimensional solid residues Leu112, 688 
Ala294 and Pro605, with their respective lateral chains, are reported on the proposed 689 
model of the WT enzyme, as well as the corresponding substituted amino acids on 690 
the model of each mutant, p.Leu112His, p.Ala294Val and p.Pro605Thr. The four 691 
amino acids involved in the catalytic site are also shown. According to these models, 692 
the p.Ala294Val and p.Pro605Thr substitutions induce a profound disorganization of 693 
the predicted immunoglobulin-like domains, with disappearance of several beta-694 
sheets, and modification of some alpha-helices of the catalytic domain, as compared 695 
to the WT. The effect of the p.Leu112His substitution is more discrete. (B) Zoom on 696 
the major amino acids involved in the catalytic site. Its proposed structure is clearly 697 
modified after p.Ala294Val and p.Pro605Thr substitutions. It should be noted that 698 
none of the substituted amino acids are directly involved in this site. 699 
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Figure 4. Overexpression of WT and mutant forms of PADI3 produced in HaCaT 700 
cell line. 701 
(A) Immunoblotting analysis shows the expression translation of WT and mutant 702 
PADI3 in transiently transfected HaCaT cells, which were collected 48 h post-703 
transfection. Immunoblotting was performed with anti-V5 and anti-PADI3 antibodies. 704 
Antibody-specific bands are indicated with an arrow and a non-specific cross-reactive 705 
band around 55 kDa is indicated with an asterisk. Full length blot images can be seen 706 
in Figure S9. (B) Immunofluorescence analysis in HaCaT cells transiently expressing 707 
transfected with WT and mutant PADI3 encoding plasmids shows the homogeneous 708 
cytosolic expression localization of WT PADI3 whereas the three mutant proteins are 709 
observed in the form of large aggregates. Scale bars, 10µm. 710 
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Figure 5. Consequences of PADI3 mutations on the enzyme activity. 711 
(A) Indirect immunofluorescence analysis of transfected HaCaT cells. HaCaT cells 712 
were double labeled with anti-V5 monoclonal antibody (green) and ACPA antibodies 713 
(red). Nuclei were labeled with DAPI (blue). Scale bars, 10 µm. The overexpressed 714 
WT PADI3 is clearly active (merge image; yellow color) whereas the mutants display 715 
a low activity. (B) WT PADI3 (bacterial clones 1 and 2) and the mutant forms, 716 
p.Leu112His (clones 7 and 8), p.Ala294Val (clones 11 and 12) and p.Pro605Thr 717 
(clones 14 and 15), expressed produced in E. coli, were extracted in Tris-HCl 718 
buffered salt. Soluble proteins were incubated for the indicated period of time (t; in 719 
hours) with calcium, separated by electrophoresis, transferred to membranes, stained 720 
with Ponceau Red and immunodetected with either the anti-modified citrulline rabbit 721 
antibodies or anti-V5 antibody. While citrullinated proteins were detected when the 722 
WT-containing extracts have been incubated for two hours, no citrullinated proteins 723 
were detected in the mutant-containing extracts, even after 18 hours of incubation. 724 
The substituted enzymes appear to be cleaved and a V5-reactive doublet is 725 
observed. Molecular mass markers are indicated on the right in kDa. Full length blot 726 
images can be seen in Figure S9.  727 
  728 
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Figure 6. Padi3 gene disruption in mice. 729 
(A) Schematic representation of the Padi3 gene and the targeting vector. The exons 730 
are shown by numbered grey rectangles. A cassette containing the beta-731 
galactosidase (LacZ) and neomycin (neo) genes is inserted between exons 4 and 5. 732 
This results in the production of a truncated Padi3 protein corresponding to amino 733 
acids 1-136 fused to β-galactosidase. The position of the inserted loxP and flippase 734 
recognition target (FRT) sites are indicated, as well as the splicing acceptor site (SA) 735 
and the polyadenylation sites (pA) of LacZ and neo. The positions of the 736 
oligonucleotides (dashes) used for genotyping are shown, as well as the length of the 737 
amplified PCR products in wildtype (Padi3wt) and targeted (Padi3tm1a) alleles. (B) 738 
PCR on genomic DNA from tail biopsies of 10 mice from the same littermate (five 739 
females, 1-5, and five males, 6-10) showing amplification of the 241 bp fragment for 740 
the Padi3wt allele and the 365 bp fragment for the Padi3tm1a allele. (C) 741 
Representative pictures of SEM analysis of back hair coat from the three wt and 742 
three Padi3tm1a/tm1a mice (7 weeks old). Most hairs of the knockout mice are 743 
rough, with an irregular surface (white arrows). This is evident for thick hairs (top and 744 
middle micrographs), but was also observed for thin hairs (bottom). In some cases 745 
the hairs are twisted. The boxed areas are enlarged in the middle.In some cases they 746 
are twisted. The boxed areas are enlarged on the bottom. At least six vibrissae and 747 
200 hairs were analyzed per animal. Scale bar = 50 µm. 748 
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Figure 7. Overexpression of WT and mutant forms of TGM3 produced in HaCaT 749 
and HEK293T cell lines 750 
(A) Immunoblotting analysis shows the expression translation of WT and truncated 751 
TGM3 in transiently transfected HaCaT cells, collected 48 h post-transfection. 752 
Immunoblotting was performed with anti-Flag and anti-TGM3 antibodies. Antibody-753 
specific bands showing the WT (~70 kDa) and truncated TGM3 (~40 kDa) are 754 
indicated with an arrow and a non-specific cross-reactive band around 55 kDa is 755 
indicated with an asterisk. The truncated TGM3 can only be detected with the 756 
antibody against the Flag epitope fused to the N-terminus and not with the antibody 757 
against the C-terminus of TGM3 as expected. Full length blot images can be seen in 758 
Figure S9. Immunoblotting analysis with HEK293T cells is presented in Figure S7. 759 
(B) Immunofluorescence analyses in HaCaT and HEK293T cells transiently 760 
expressing transfected with WT and mutant TGM3 encoding constructs are 761 
presented by images captured with 10x and 63x objectives. The analyses show clear 762 
differences in the number of cells expressing producing the WT and mutant TGM3 763 
(10x images). Scale bars, 50 µm and 10 µm for 10x and 63x objectives, respectively. 764 
(C) Transglutaminase activity of WT and mutated TGM3 overexpressed produced in 765 
HEK293T cells. Mock transfected cell lysates were used as negative control. The 766 
transglutaminase activity, represented by the mean slope of 10-minute long 767 
measurements from technical triplicates (given in Figure S8), is presented as a dot 768 
plot. The enzymatic activity assay was performed with samples emerging from five 769 
independent transfections. Horizontal lines represent the mean values (mean ± SD; 770 
WT: 0.84±0.45; p.Gln451*: 0.10±0.04; mock: 0.07±0.02). Results demonstrate that 771 
the mutated protein did not differ from the mock transfected negative control in terms 772 
of activity and WT TGM3 had a significantly higher activity in comparison to both 773 
(*P<0.05, Dunn’s Test). 774 
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Table 1. Individuals carrying PADI3, TGM3 and TCHH mutations 775 
 776 
Country Gene Mutation Consequence  Clinical description 
United 
Kingdom 
PADI3 c.881C>T, homozygous p.Ala294Val This study 
Denmark PADI3 c.881C>T, homozygous p.Ala294Val 
Nissen and Svendsen 
2013 24 
Germany PADI3 c.335T>A, homozygous p.Leu112His This study 
Spain PADI3 c.881C>T, c.335T>A p.Ala294Val, p.Leu112His Novoa et al. 2012 25 
Germany PADI3 c.881C>T, c.335T>A p.Ala294Val, p.Leu112His This study 
Germany PADI3 c.881C>T, c.335T>A p.Ala294Val, p.Leu112His This study 
Germany PADI3 c.881C>T, c.1813C>A p.Ala294Val, p.Pro605Thr This study 
Germany PADI3 c.335T>A, c.1813C>A p.Leu112His, p.Pro605Thr This study 
Switzerland PADI3 c.881C>T, c.1732A>T  p.Ala294Val, p.Lys578* This study 
Turkey TGM3 c.1351C>T, homozygous p.Gln451* Kilic et al. 2013 26 
Germany TCHH c.991C>T, homozygous p.Gln331* This study 
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